We distill cutting-edge medical technologies to their essence, then re-invent them as affordable, reliable, easy-to-use tools that work in places where resources are limited, power is scarce, or trained health care workers are few and far between.
Family planning advocates can ensure that a country’s policies and funding promote access to all contraceptive options, so women can make an informed and voluntary choice. The Advocacy Pack for Subcutaneous DMPA was designed for advocates around the globe to help increase access to this new injectable contraceptive option.
Research in Uganda and elsewhere has shown that women are able to self-administer DMPA-SC safely and effectively, that they like doing so, and that self-injection helps support women to continue using injectable contraception.
Several thousands of health workers around the world have been trained to safely provide DMPA-SC injections in clinics, community locations, and villages, and even to support women to self-inject.
Family planning leaders can draw from an established base of evidence to integrate DMPA-SC in efforts to address unmet need and increase access to contraception through a range of delivery channels.
A new initiative led by PATH in partnership with John Snow, Inc., the DMPA-SC Access Collaborative works with ministries of health and partners to strengthen scale-up and build a robust global market for DMPA-SC as an important addition to the full range of contraceptive options.
What happened at the global challenge to complete the design of the RELI pump.